A 36-week exercise program may reverse frailty in older adults — a community trial puts it to the test

NCT ID NCT07732478

First seen Jul 29, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests whether a 36-week community-based exercise program can improve physical function and reduce frailty and sarcopenia in adults aged 65 and older living independently in Santoña, Spain. The program includes strength, balance, endurance, and flexibility exercises based on the Vivifrail model. Researchers will measure balance, gait speed, chair-stand performance, handgrip strength, and walking capacity before and after each cycle. The goal is to see if real-world participation in such a program leads to meaningful improvements in mobility and muscle health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 36-week community-based multicomponent exercise program (Vivifrail-based) focusing on strength, balance, endurance, and flexibility
What this could lead to
If effective, this program could offer a practical, scalable way to improve mobility and reduce frailty in older adults living independently.
What could go wrong
This is a quasi-experimental study, not a randomized trial, so results may be influenced by factors other than the exercise program. The program is delivered in a real-world setting, which may limit consistency.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY IN OLDER ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Sports Science

    Granada, Andalusia, 18004, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.